FIM
PRAH

Freedom Investment Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Freedom Investment Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,263
Closed -$209K – 944
2021
Q2 		$209K Buy
+1,263
New +$211K 0.02% 810
2020
Q2 		– Sell
-2,638
Closed -$281K – 710
2020
Q1 		$281K Buy
+2,638
New +$257K 0.02% 526
2019
Q3 		– Sell
-3,687
Closed -$366K – 750
2019
Q2 		$366K Sell
3,687
-1,017
-22% -$97.1K 0.03% 450
2019
Q1 		$519K Sell
4,704
-763
-14% -$79.7K 0.04% 374
2018
Q4 		$503K Buy
5,467
+1,867
+52% +$189K 0.04% 424
2018
Q3 		$387K Buy
3,600
+387
+12% +$40.3K 0.02% 624
2018
Q2 		$300K Sell
3,213
-2
-0.1% -$172 0.02% 761
2018
Q1 		$267K Sell
3,215
-1,391
-30% -$124K 0.01% 918
2017
Q4 		$419K Sell
4,606
-219
-5% -$18.2K 0.02% 714
2017
Q3 		$368K Buy
4,825
+608
+14% +$46K 0.02% 742
2017
Q2 		$316K Buy
4,217
+259
+7% +$18K 0.02% 766
2017
Q1 		$258K Buy
+3,958
New +$233K 0.02% 842

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Freedom Investment Management's PRAH Position: Q3 2021 in Review

Freedom Investment Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 1,263 shares — an estimated $209K sold.

Freedom Investment Management first reported a position in PRAH in Q1 2017 and held it in 12 quarters. The position peaked at $519K in Q1 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Freedom Investment Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Freedom Investment Management sold 1,263 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $209K.
  • Freedom Investment Management first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 12 quarters.
  • Freedom Investment Management's PRA Health Sciences, Inc. position peaked at $519K in Q1 2019.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Freedom Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.